HVH and Patient iP Team Up to Improve Clinical Trials
KING OF PRUSSIA, Pa. and ROCHESTER, N.Y., Feb. 13, 2018 /PRNewswire/ -- HVH Precision Analytics, a predictive analytics company accelerating the effective use of machine learning on the real-world data landscape to help healthcare organizations attain actionable results, and Patient iP, a health data and analytics company providing patient data insights to accelerate and transform clinical research, are partnering to improve clinical trial design, site selection and patient enrollment.
The companies will collaborate using HVH's proprietary SCIPHER™ machine learning platform and Patient iP's proprietary daTAscape asset to better target clinical trial sites and accelerate trial enrollment. HVH combines data and therapeutic area agnostic analytic and medical capabilities, and Patient iP's platform contains data from more than 4,000 practice sites and 16 million ambulatory electronic medical records (EMR). The combination will bring powerful changes to clinical trials.
"Coupling HVH's unique machine learning capabilities broadly applied to real-world data and Patient iP's significant EMR and site access will significantly improve our companies' ability to assist CROs and clinical trial sponsors with site selection and targeting, leading to improved trial enrollment," said Steve Costalas, CEO of HVH.
"Patient iP is excited to partner with HVH given their rich heritage of predictive analytics and innovation. By integrating their significant data science capabilities with our robust identifiable patient database and deep clinical trial expertise, we offer a new data-driven approach to solving the patient recruitment challenges in clinical research," said Mike Wilkinson, President and COO of Patient iP.
About HVH
HVH is a proven provider of predictive analytics solutions. HVH is shortening the time to diagnosis through the application of a proven and validated methodology to real-world data to find diagnosed patients, prospective therapy candidates, undiagnosed patients and ideal candidates for clinical trials so that innovative therapies find the patients who desperately need them. For more information about HVH, visit www.hvhprecision.com.
About Patient iP
The patented Patient iP data analytics platform provides unique value for the clinical research industry. Using a cloud-based infrastructure, the company leverages aggregated patient data to streamline and accelerate clinical trial design, site selection and participant matching to bring new therapies to market faster and more cost effectively. Deployed in concert, Patient iP's award-winning technology and expansive daTAscape™ enhance recruitment efforts, increase performance predictability, and maximize research yield given a focus on the untapped community-based patient market. For more information, visit us at www.patientip.com or follow us on Twitter @PatientIP.
SOURCE HVH Precision Analytics
Share this article